Prothena Corporation PLC PRTA.OQ PRTA.O is expected to show a rise in quarterly revenue when it reports results on November 6 for the period ending September 30 2025
The Dublin Ireland-based company is expected to report a 584.4% increase in revenue to $6.639 million from $970 thousand a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Prothena Corporation PLC is for a loss of 69 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Prothena Corporation PLC is $14.50, about 27.3% above its last closing price of $10.54
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -1.72 | -1.32 | -1.73 | Missed | -31.4 |
Mar. 31 2025 | -0.95 | -0.97 | -1.12 | Missed | -15.1 |
Dec. 31 2024 | -1.06 | -1.04 | -1.08 | Missed | -3.6 |
Sep. 30 2024 | -1.17 | -1.18 | -1.10 | Beat | 6.6 |
Jun. 30 2024 | -1.02 | -1.05 | 1.22 | Beat | 215.8 |
Mar. 31 2024 | -1.20 | -1.20 | -1.34 | Missed | -11.6 |
Dec. 31 2023 | -1.24 | -1.22 | -1.26 | Missed | -3.6 |
Sep. 30 2023 | -0.35 | -0.32 | 0.38 | Beat | 218 |
This summary was machine generated November 4 at 21:57 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)